Strategies for molecular intervention in esophageal cancers and their precursor lesions

D S Schrump1, D M Nguyen

  • 1Thoracic Oncology Section, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Insights

Understanding genetic changes in Barrett's esophagus helps identify key events in esophageal cancer development. This research targets pathways like retinoblastoma (Rb) and p53 for new treatments and prevention strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Barrett's esophagus is a precursor to esophageal adenocarcinoma.
  • Multistep carcinogenesis involves accumulating genetic alterations.
  • Understanding these alterations is crucial for targeted therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms of malignant transformation in Barrett's epithelium.
  • To identify critical genetic events in multistep esophageal carcinogenesis.
  • To provide a basis for novel therapeutic and chemopreventive strategies.

Main Methods:

  • Molecular analysis of genetic events in Barrett's epithelium.
  • Investigation of tumor-suppressor pathways (e.g., retinoblastoma, p53).
  • Analysis of tyrosine kinase cascades involved in cell cycle progression.

Main Results:

  • Identified the temporal sequence and significance of genetic events.
  • Highlighted the role of Rb and p53 pathway mutations.
  • Demonstrated the involvement of tyrosine kinase signaling in esophageal neoplasms.

Conclusions:

  • Molecular insights into Barrett's esophagus aid in understanding esophageal cancer progression.
  • Targeting specific genetic pathways (Rb, p53, tyrosine kinases) offers therapeutic potential.
  • Findings support the development of pharmacologic interventions and chemoprevention for at-risk patients.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...